Transaction · 0001437749-26-029257

Jorden David Emerson

JORDEN DAVID EMERSON, CEO, CFO, reported an open-market or private purchase at Nuo Therapeutics, Inc. involving 789.000000 shares for an estimated $844.23. Reported holdings after the transaction were 2062016.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO, CFO
AURXNuo Therapeutics, Inc.
Trade date
Aug 27, 2026
Filing date
Aug 31, 2026
View on SEC Insider profile
Estimated value$844Shares × reported price
Shares traded789$1.07 per share
Holdings after2.06MDirect
% of reported position traded0.04%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 2,061,227 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
amended filingThis transaction comes from an amended Form 4 filing.

AURX price since this filing

Daily closing prices, with the filing date and available return windows
AURX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001437749-26-029257
Common Stock
Transaction date
Aug 27, 2026
Filed Aug 31, 2026, 02:29 PM · 4d delay
Shares
789 sh
$1.07 per share
Estimated value
$844
Computed from shares × price
Holdings after
2,062,016 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing Director Buy Direct Ownership
Filing-only score

+24 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • ceo_buy+12 points

    is_officer + officer_title/role mentions CEO

    CEO open-market purchase.
  • amended_filing-6 points

    is_amendment = true

    Amended filing: the original transaction may have been restated.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO/CFO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.10, inclusive. The reporting person undertakes to pr…

Amended filing · 0001437749-26-029257
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

AURX